Advertisement
Screener

Allurion Technologies, Inc. (ALUR) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

Allurion Technologies, Inc. Capital Expenditures

Allurion Technologies, Inc. (ALUR) reported Capital Expenditures of $611.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-30

  • Allurion Technologies, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
  • Allurion Technologies, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $72.00K, a 91.00% decline year-over-year.
  • Allurion Technologies, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-06-30 was $435.00K, a 232.06% increase year-over-year.
  • Allurion Technologies, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-03-31 was $104.00K, a 62.45% decline year-over-year.
  • Allurion Technologies, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $611.00K, a 61.96% decline from fiscal 2023.
  • Allurion Technologies, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $1.61M, a 3.61% increase from fiscal 2022.
  • Allurion Technologies, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $1.55M.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$72.00K
derived: sum of 2 quarters · filed 2026-03-30
$507.00K
derived: sum of 3 quarters · filed 2026-03-30
$611.00K
10-K · filed 2026-03-30
2024-09-30$72.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-17
$507.00K
derived: sum of 2 quarters · filed 2025-11-17
$611.00K
10-Q · filed 2025-11-17
$1.01M
derived: sum of 4 quarters · filed 2025-11-17
2024-06-30$435.00K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28
$539.00K
10-Q/A · filed 2025-08-28
$937.00K
derived: sum of 3 quarters · filed 2025-08-28
$1.74M
derived: sum of 4 quarters · filed 2025-08-28
2024-03-31$104.00K
10-Q/A · filed 2025-08-28
$502.00K
derived: sum of 2 quarters · filed 2025-08-28
$1.30M
derived: sum of 3 quarters · filed 2025-08-28
$1.43M
derived: sum of 4 quarters · filed 2025-08-28
2023-12-31$398.00K
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28
$1.20M
derived: sum of 2 quarters · filed 2025-08-28
$1.33M
derived: sum of 3 quarters · filed 2025-08-28
$1.61M
10-K/A · filed 2025-08-28
2023-09-30$800.00K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-08-28
$931.00K
derived: sum of 2 quarters · filed 2025-08-28
$1.21M
10-Q/A · filed 2025-08-28
$1.67M
derived: sum of 4 quarters · filed 2025-08-28
2023-06-30$131.00K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28
$408.00K
10-Q/A · filed 2025-08-28
$867.00K
derived: sum of 3 quarters · filed 2025-08-28
$710.00K
derived: sum of 4 quarters · filed 2025-08-28
2023-03-31$277.00K
10-Q/A · filed 2025-08-28
$736.00K
derived: sum of 2 quarters · filed 2025-08-28
$579.00K
derived: sum of 3 quarters · filed 2025-08-28
2022-12-31$459.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28
$302.00K
derived: sum of 2 quarters · filed 2025-08-28
$1.55M
10-K/A · filed 2025-08-28
2022-09-30-$157.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$1.09M
10-Q · filed 2023-11-14
2022-06-30$1.25M
10-Q · filed 2023-10-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
Picard Medical, Inc. (PMI)United States$0.011B-0.01
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
CERENOME, INC. (CNSY)United States$0.014B
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
AETHLON MEDICAL INC (AEMD)United States$0.005B